Dignity Health and Aetna are in negotiations.
For more information, call 877-729-2669 or visit www.dignityhealth.org/aetna.
HEADSMART II - Head injury serum markers
Study to develop an In-Vitro Diagnostic, the BRAINBox TBI test, to aid in the diagnosis and prognosis of patients with mild traumatic brain injury (TBI), by incorporating blood biomarkers, clinical assessments, and tools to measure associated neurocognitive impairments.
Principal Investigator: Brian Tiffany, MD, PhD
https://clinicaltrials.gov/ct2/show/NCT04423198?term=headsmart+II&draw=2&rank=1
For questions please call: 480-601-5411
Evaluation of BE1116 in patients with Traumatic Injury
Study to investigate the efficacy and safety of a single IV infusion of BE1116 in subjects who have traumatic injury, with confirmed or suspected acute major bleeding and/or predicted to receive a large volume blood product transfusion.
Principal Investigator: Charles Hu, MD
https://clinicaltrials.gov/ct2/show/NCT05568888?term=BE1116&cond=traumatic+injury&draw=2&rank=1
For questions please call: 480-601-5411
Arrhythmia
Cardiac Genomics
Coronary Artery Disease
Heart Failure
Structural Heart
Brain Tumors - Neuro Oncology
COVID-19
Infectious Disease
Peripheral Artery Disease
Point of Care
Stroke
Trauma
